• Corpus ID: 24690733

Comparison of Calcium Hydroxide and Bioactive Glass after Direct Pulp Capping in Primary Teeth

  title={Comparison of Calcium Hydroxide and Bioactive Glass after Direct Pulp Capping in Primary Teeth},
  author={Roza Haghgoo and Nooshin Jalayer Naderi},
  journal={Journal of Dentistry},
Objective: Bioactive glass is often used as a filler material for repair of dental bone defects. In different studies osteogenic potential of this material was proved, but its dentinogenesis property is in doubt. The purpose of this study was to evaluate the histological pulp responses of Calcium hydroxide and Bioactive glass placed directly on exposed pulp tissues. Materials and Methods: Twenty teeth to be extracted due to orthodontic reasons were selected. These teeth were divided into two… 

Figures and Tables from this paper

Evaluation of pulpal response of deciduous teeth after direct pulp capping with bioactive glass and mineral trioxide aggregate
MTA and BAG can be used for DPC of primary teeth after direct pulp capping with two biocompatible materials namely mineral trioxide aggregate and bioactive glass.
Simvastatin versus Calcium Hydroxide Direct Pulp Capping of Human Primary Molars: A Randomized Clinical Trial
The findings of this study depicted that healing with no inflammation and hard tissue formation following statin treatment occurs with a lower rate than that with the calcium hydroxide.
Bioactive Glass Modified Calcium Phosphate Cement with Improved Bioactive Properties: A Potential Material for Dental Pulp-Capping Approaches
Direct pulp capping (DPC) is one of the treatment plans for deep caries with mechanical pulp exposure that can replace invasive treatments. This study aimed to assess the apatite-forming ability and
The In Vitro Evaluation of Calcium and Bioactive Glass Based Pulp Capping Materials
Vital pulp therapy aims the treatment of reversible pulp injuries that occur during caries or trauma by preserving pulp vitality and function [1]. The placement of a biocompatible material that
Bioactivity assessment of bioactive glasses for dental applications: A critical review.
The aim of this review was to identify, clarify, and classify the methodologies used to quantify the bioactive glasses bioactivity, and suggested a classification of methodologies for a better understanding of theBioactive properties of BAG.
Direct pulp capping versus pulpotomy with MTA for carious primary molars: a randomised clinical trial
The results of the current trial indicate that both DPC and pulpotomy can be reliable options for the treatment of deep carious primary molars in cooperative children, in carefully selected cases.
Loading of gentamicin onto poly lactic-co-glycolic acid and poly lactic-coglycolic acid/nano-hydroxyapatite composite microspheres.
The release profiles observed and the well-established biocompatibility of PLGA indicate that the composite microspheres used in this study are suitable for infection control purposes in dentistry.


Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects.
Although the clinical results are encouraging and radiographs evidenced radiopacities within the defects, histologic analysis revealed that as a periodontal grafting material, bioactive glass ceramic has only limited regenerative properties.
Tunnel defects in dentin bridges: their formation following direct pulp capping.
The need to employ biologically relevant measures that will provide a long-term clinical seal against microleakage following direct pulp capping with Ca(OH)2 medicaments alone is reemphasized.
Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar.
It appeared that BAG induced an inflammatory response at 2 weeks with resolution of inflammation at 4 weeks, and MTA performed ideally as a pulpotomy agent causing dentine bridge formation while simultaneously maintaining normal pulpal histology.
Bioactive glass particulate material as a filler for bone lesions.
The aim of the present study was to evaluate bioactive glass granules (Biogran) as a filler for osseous lesions, and to compare them with two commercially available Hydroxylapatite (HA) granules.
Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome.
Implants will survive for up to 3 years in sites grafted with bioactive glass, even when such grafts appear to only slowly conduct new bone growth, as seen histologically.
Pulp capping of dental pulp mechanically exposed to oral microflora: a 1-2 year observation of wound healing in the monkey.
It is demonstrated that recurring pulp inflammation observed after 1 & 2 year direct pulp capping, is associated with bacterial contamination.
Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
It can be concluded that both therapies led to significant improvements of the investigated clinical parameters, and the combination of enamel matrix derivative and bioactive glass does not seem to additionally improve the clinical outcome of the therapy.
Clinical use of a bioactive glass particulate in the treatment of human osseous defects.
Clinical experiences with PerioGlas are reviewed in the setting of private practice periodontics, in which this material was used as the grafting material for periodontal defects, apicoectomies, cysts, and ridge augmentation and maintenance procedures, as well as for implant repairs.
Clinical comparison of bioactive glass bone replacement graft material and expanded polytetrafluoroethylene barrier membrane in treating human mandibular molar class II furcations.
The findings of this study suggest essentially equal clinical results with PG bone replacement graft material and e-PTFE barriers in mandibular molar Class II furcations.
Pulp response to ferric sulfate, diluted formocresol and IRM in pulpotomized primary baboon teeth.
This study investigated the pulp response to a 15.5 percent ferric sulfate solution (FS) and a 20 percent dilution of formocresol (DFC) in pulpotomized primary teeth of baboons, after four and eight